Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) FCF Margin (2020 - 2022)

RAPT Therapeutics' FCF Margin history spans 3 years, with the latest figure at 1778.89% for Q2 2022.

  • For Q2 2022, FCF Margin fell 17015.0% year-over-year to 1778.89%; the TTM value through Mar 2023 reached 8493.23%, down 653249.0%, while the annual FY2022 figure was 4689.98%, 306971.0% down from the prior year.
  • FCF Margin for Q2 2022 was 1778.89% at RAPT Therapeutics, up from 2453.51% in the prior quarter.
  • Across five years, FCF Margin topped out at 503.29% in Q2 2020 and bottomed at 2787.7% in Q4 2021.
  • The 3-year median for FCF Margin is 1248.38% (2020), against an average of 1439.12%.
  • The largest annual shift saw FCF Margin crashed -159415bps in 2021 before it tumbled -17015bps in 2022.
  • A 3-year view of FCF Margin shows it stood at 1193.55% in 2020, then tumbled by -134bps to 2787.7% in 2021, then surged by 36bps to 1778.89% in 2022.
  • Per Business Quant, the three most recent readings for RAPT's FCF Margin are 1778.89% (Q2 2022), 2453.51% (Q1 2022), and 2787.7% (Q4 2021).